XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.19.2

Accrued Expenses | 3 Months Ended
--- | ---
Mar. 31, 2019
Payables And Accruals [Abstract] |
Accrued Expenses |
(6) | Accrued Expenses
Accrued expenses consist of the following:
|  | March 31, |  |  | December 31, |
(in thousands) |  | 2019 |  |  | 2018 |
Compensation, excluding taxes |  | $ | 3,122 |  |  | $ | 1,785 |
Clinical trial expenses |  |  | 4,151 |  |  |  | 4,530 |
Other1 |  |  | 1,087 |  |  |  | 1,649 |
Total accrued expenses |  | $ | 8,360 |  |  | $ | 7,964 |
1 Other consists of various accrued expenses, with no individual item accounting for more than 5% of current liabilities at March 31, 2019 and December 31, 2018.

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration